This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IDEXX Laboratories Inc (IDXX)

NASDAQ: Health Care

Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 1.49B 1.38B 1.29B 1.22B
Cost of Sales 610.80M 566.34M 541.78M 523.98M
Gross Operating Profit 875.00M 810.71M 751.56M 694.71M
Selling, General, and Administrative Expenses 457.60M 401.35M 354.57M 334.24M
Research & Development 98.26M 88.00M 82.01M 76.04M
Operating Income before D & A (EBITDA) 319.14M 321.36M 314.97M 284.43M
Depreciation & Amortization 58.89M 54.60M 52.41M 48.20M
Interest Income 1.73M 1.88M 1.90M 1.74M
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 261.98M 268.65M 264.46M 237.97M
Interest Expense 15.43M 5.39M 3.85M 3.55M
Pre-Tax Income 246.56M 263.26M 260.62M 234.42M
Income Taxes 64.60M 75.47M 82.33M 72.67M
Minority Interest 45.00K -6.00K 20.00K -32.00K
Net Income From Continuing Operations 181.95M 187.79M 178.29M 161.75M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 181.95M 187.79M 178.29M 161.75M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 181.91M 187.80M 178.27M 161.79M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
181.95M 187.79M 178.29M 161.75M
Preferred Dividends
Net Income Available To Common 181.95M 187.79M 178.29M 161.75M
Basic EPS from Continuing Ops. 1.82 1.77 1.62 1.42
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.82 1.77 1.62 1.42
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.82 1.77 1.62 1.43
Basic Normalized Net Income/Share 1.82 1.77 1.62 1.42
EPS fr Continuing Ops. 1.79 1.74 1.59 1.39
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.79 1.74 1.59 1.39
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.79 1.74 1.59 1.39
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.79 1.74 1.59 1.39
Dividends Paid per Share 0.00 0.00 0.00 0.00
IDXX News

IDXX IDEXX Laboratories Inc

Chart of IDXX

Analysts Ratings for IDXX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 1 1 1 1
Hold 2 2 1 1
Moderate Sell 0 0 0 0
Strong Sell 1 1 2 2
GET IDXX ANALYST REPORT

Brokerage Partners

IDXX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs